Cleerly
Cleerly Raises $106M Series C | AI Heart Disease Detection
Cleerly Closes $106M for Cardiac AI Platform
Cleerly, a digital healthcare company that offers heart disease diagnosis solutions using AI, has raised $106 million in Series C funding.
The round was led by Insight Partners with participation from Battery Ventures and Vensana Capital.
Key Highlights
- Total funding to date: $386.5 million
- AI-powered coronary artery disease detection
- FDA-cleared diagnostic platform
Company Overview
Cleerly has developed an AI-powered cardiac care platform that analyzes heart scans to detect and characterize coronary artery disease with higher accuracy than traditional methods.
Company Info
Investors (3)
Share
Related Reports
Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform
Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.
Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation
French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.
AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment
Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free